We are live on
!
Find out more
RVNC
Revance Therapeutics, Inc.
RVNC
RVNC
Delisted
RVNC was delisted on the 5th of February, 2025.
74 hedge funds and large institutions have $463M invested in Revance Therapeutics, Inc. in 2016 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 30 increasing their positions, 25 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
20% more repeat investments, than reductions
Existing positions increased: 30 | Existing positions reduced: 25
18% more capital invested
Capital invested by funds: $391M → $463M (+$71.8M)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
10% less funds holding
Funds holding: 82 → 74 (-8)
67% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 12
91% less call options, than puts
Call options by funds: $16K | Put options by funds: $178K
Holders
74
Holders Change
-8
Holders Change %
-9.76%
% of All Funds
1.97%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
4
Increased
30
Reduced
25
Closed
12
Calls
$16K
Puts
$178K
Net Calls
-$162K
Net Calls Change
-$749K
Top Buyers
Top Sellers
| 1 |
Bank of New York Mellon
New York
|
-$2.84M |
| 2 |
State Street
Boston,
Massachusetts
|
-$1.77M |
| 3 |
IHM
Iguana Healthcare Management
New York
|
-$1.36M |
| 4 |
Baird Financial Group
Milwaukee,
Wisconsin
|
-$1.28M |
| 5 |
SCM
Suffolk Capital Management
New York
|
-$982K |
